(19)
(11) EP 1 011 705 A2

(12)

(88) Date of publication A3:
15.04.1999

(43) Date of publication:
28.06.2000 Bulletin 2000/26

(21) Application number: 98939226.1

(22) Date of filing: 05.08.1998
(51) International Patent Classification (IPC)7A61K 38/00, A61K 38/04, A61K 38/08
(86) International application number:
PCT/US9816/290
(87) International publication number:
WO 9907/324 (18.02.1999 Gazette 1999/07)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 05.08.1997 US 914042

(71) Applicant: Watson Pharmaceuticals, Inc.
Corona, CA 91720 (US)

(72) Inventor:
  • PRAKASH, Ramesh, K.
    Salt Lake City, UT 84121 (US)

(74) Representative: Sexton, Jane Helen et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) CONJUGATES TARGETED TO THE INTERLEUKIN-2 RECEPTOR